Keywords
MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPandemicIntensive care medicineVirologyOutbreakDiseasePathologyInfectious disease (medical specialty)
Affiliated Institutions
Related Publications
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral...
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
The safety and immunogenicity data from this U.S. phase 1 trial of two vaccine candidates in younger and older adults, added to earlier interim safety and immunogenicity data re...
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
At 35 days, NVX-CoV2373 appeared to be safe, and it elicited immune responses that exceeded levels in Covid-19 convalescent serum. The Matrix-M1 adjuvant induced CD4+ T-cell res...
Publication Info
- Year
- 2016
- Type
- editorial
- Volume
- 14
- Issue
- 1
- Pages
- 212-212
- Citations
- 46
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
46
OpenAlex
Cite This
Amanda Rojek,
Peter Horby
(2016).
Modernising epidemic science: enabling patient-centred research during epidemics.
BMC Medicine
, 14
(1)
, 212-212.
https://doi.org/10.1186/s12916-016-0760-x
Identifiers
- DOI
- 10.1186/s12916-016-0760-x